David Grossman
Stock Analyst at Stifel
(3.87)
# 593
Out of 4,814 analysts
154
Total ratings
57.14%
Success rate
4.83%
Average return
Main Sectors:
Stocks Rated by David Grossman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INFY Infosys | Maintains: Hold | $22 → $18 | $16.15 | +11.49% | 10 | Apr 15, 2025 | |
| DRIO DarioHealth | Maintains: Buy | $3.5 → $2 | $0.75 | +167.59% | 4 | Mar 11, 2025 | |
| DCGO DocGo | Maintains: Buy | $6.5 → $5.5 | $2.12 | +160.05% | 9 | Feb 28, 2025 | |
| HCAT Health Catalyst | Maintains: Hold | $10 → $5 | $3.85 | +29.87% | 5 | Feb 27, 2025 | |
| EXLS ExlService Holdings | Maintains: Buy | $48 → $54 | $44.84 | +20.43% | 1 | Feb 27, 2025 | |
| ACN Accenture | Maintains: Buy | $390 → $380 | $282.40 | +34.56% | 26 | Feb 26, 2025 | |
| AMWL American Well | Maintains: Hold | $9 → $10 | $6.99 | +43.06% | 2 | Feb 13, 2025 | |
| VEEV Veeva Systems | Maintains: Buy | $240 → $272 | $220.66 | +23.27% | 7 | Dec 6, 2024 | |
| OPRX OptimizeRx | Maintains: Buy | $13 → $8 | $8.46 | -5.44% | 6 | Nov 14, 2024 | |
| IBM International Business Machines | Maintains: Buy | $205 → $246 | $238.94 | +2.95% | 20 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $130 → $141 | $144.90 | -2.69% | 9 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $16 → $9 | $6.83 | +31.77% | 10 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $271 → $287 | $293.28 | -2.14% | 10 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $7.5 | $2.53 | +197.03% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $21 → $19 | $14.64 | +29.78% | 10 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $117 → $121 | $76.02 | +59.17% | 11 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $288 → $301 | $146.80 | +105.04% | 11 | Feb 12, 2024 |
Infosys
Apr 15, 2025
Maintains: Hold
Price Target: $22 → $18
Current: $16.15
Upside: +11.49%
DarioHealth
Mar 11, 2025
Maintains: Buy
Price Target: $3.5 → $2
Current: $0.75
Upside: +167.59%
DocGo
Feb 28, 2025
Maintains: Buy
Price Target: $6.5 → $5.5
Current: $2.12
Upside: +160.05%
Health Catalyst
Feb 27, 2025
Maintains: Hold
Price Target: $10 → $5
Current: $3.85
Upside: +29.87%
ExlService Holdings
Feb 27, 2025
Maintains: Buy
Price Target: $48 → $54
Current: $44.84
Upside: +20.43%
Accenture
Feb 26, 2025
Maintains: Buy
Price Target: $390 → $380
Current: $282.40
Upside: +34.56%
American Well
Feb 13, 2025
Maintains: Hold
Price Target: $9 → $10
Current: $6.99
Upside: +43.06%
Veeva Systems
Dec 6, 2024
Maintains: Buy
Price Target: $240 → $272
Current: $220.66
Upside: +23.27%
OptimizeRx
Nov 14, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $8.46
Upside: -5.44%
International Business Machines
Oct 16, 2024
Maintains: Buy
Price Target: $205 → $246
Current: $238.94
Upside: +2.95%
Oct 2, 2024
Maintains: Hold
Price Target: $130 → $141
Current: $144.90
Upside: -2.69%
Aug 1, 2024
Maintains: Hold
Price Target: $16 → $9
Current: $6.83
Upside: +31.77%
Aug 1, 2024
Maintains: Hold
Price Target: $271 → $287
Current: $293.28
Upside: -2.14%
Jul 31, 2024
Maintains: Buy
Price Target: $9.5 → $7.5
Current: $2.53
Upside: +197.03%
May 17, 2024
Maintains: Hold
Price Target: $21 → $19
Current: $14.64
Upside: +29.78%
Feb 16, 2024
Maintains: Buy
Price Target: $117 → $121
Current: $76.02
Upside: +59.17%
Feb 12, 2024
Maintains: Buy
Price Target: $288 → $301
Current: $146.80
Upside: +105.04%